Health-related quality of life in women with breast cancer undergoing autologous stem-cell transplantation

Cancer Nursing

Volumn 19, Issue 5, 1996, Pages 368-375

  Larsen, Joacim ^a   Gardulf, Ann ^a   Nordström, Gun ^b   Björkstrand, Bo ^a   Ljungman, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Autologous stem cell transplantation; Breast cancer; Health; High dose chemotherapy; Quality of life

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; THIOTEPA;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DRUG MEGADOSE; EMOTIONAL STABILITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0029818540     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-199610000-00006     Document Type: Article

References (39)

1. Socialstyrelsen. The Swedish Cancer Registry. Cancer incidence in Sweden 1991. Stockholm: Center of Epidemiology, Socialstyrelsen (The National Board of Health and Welfare), 1994.
2. Antman K. Dose-intensive therapy in breast cancer. In: Armitage J, Antman K, eds. High-dose cancer therapy: pharmacology, hematopoietins, stem cells. Baltimore: Williams and Wilkins, 1992:701-18.
3. de Graaf H, Willemse PHB, de Vries EGE, et al. Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes. Eur J Cancer 1994;30A: 150-3.
4. Gale RP, Armitage JO, Dicke KA. Autotransplants: now and in the future. Bone Marrow Transplant 1991;7:153-7.
5. Peters WP, Shpall EJ, Jones RB, et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988;6:1368-76.
6. Peters WP. Autologous bone marrow transplantation for breast cancer. Curr Opin Oncol 1992;4:279-82.
7. Antman K, Corringham R, de Vries E, et al. Dose-intensive therapy in breast cancer. Bone Marrow Transplant 1992;10: 67-73.
8. Gratwohl A, Hermans J, Goldman JM, Gahrton G. Bone marrow transplantation in Europe: major geographical differences. J Intern Med 1993;233:333-41.
9. Wujik D. Current research in side effects of high-dose chemotherapy. Semin Oncol Nurs 1992;8:102-12.
10. Ford R, Eisenberg S. Bone marrow transplant: recent advances and nursing implications. Nurs Clin North Am 1990;25:405- 22.
11. Hooper P, Santas E. Peripheral blood stem cell transplantation. Oncol Nurs Forum 1993;20:1215-23.
12. Mack CH. Assessment of the autologous bone marrow transplant patient according to Orem's self care model. Cancer Nurs 1992;15:429-36.
13. Lesko LM. Psychiatric aspects of bone marrow transplantation. Part II. Life beyond transplant. Psycho-Oncology 1993;2:185- 93.
14. Ferrell B, Grant M, Schmidt G, et al. The meaning of quality of life for bone marrow transplant survivors. Part I. The impact of bone marrow transplant on quality of life. Cancer Nurs 1992;15:153-60.
15. Winer EP. Quality-of-life research in patients with breast cancer. Cancer 1994;74:410-5.
16. Ayash LJ, Eilas A, Wheeler C, et al. Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. J Clin Oncol 1994;12:37-44.
17. Bergner M, Bobbin RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
18. Augustinsson LE, Sullivan L, Sullivan M. Physical, psychologic and social function in chronic pain patients after epidural spinal electrical stimulation. Spine 1986;11:111-9.
19. Sullivan M, Ahlḿn M, Archenholtz B, Svensson G. Measuring health in rheumatic disorders by means of a Swedish version of the Sickness Impact Profile. Scand J Rheumatol 1986;15: 193-200.
20. Sullivan M, Ahlmén M, Bjelle A. Health status assessment in rheumatoid arthritis. 1. Further work on the validity of the Sickness Impact Profile. J Rheumatol 1990;17:439-47.
21. Ahlmén EM, Bengtsson CB, Sullivan BM, Bjelle A. A comparison of overall health between patients with rheumatoid arthritis and a population with and without rheumatoid arthritis. Scand J Rheumatol 1990;19:413-21.
22. Gardulf A, Björvell H, Gustafson R, Hammarström L, Smith CIE. The life situation of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol 1993;92:200-4.
23. Langius A, Björvell H, Lind MG. Functional Status and coping in patients with oral and pharyngeal cancer before and after surgery. Head Neck 1994;16:559-68.
24. Langius A, Björvell H. Coping ability and functional status in a Swedish population sample. Scand J Caring Sci 1993;7:3- 10.
25. Brorsson B, Ifver J, Hays RD. The Swedish Health-Related Quality of Life Survey (SWED-QUAL). Qual Life Res 1993;2: 33-45.
26. Hart LG, Evans RW. The functional status of ESRD patients as measured by the Sickness Impact Profile. J Chron Dis 1987;40:117S-30S.
27. Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993;11:319-27.
28. Davis GL, Balart LA, Schiff ER, et al. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther 1994;16:334-43.
29. Deyo RA, Diehl AK, Rosenthal M. How many days of bed rest for acute low back pain? N Engl J Med 1986;315:1064- 70.
30. Siegel S, Castellan Jr NJ. The Friedman two-way analysis of variance by ranks. In: Nonparametric statistics for the behavioral sciences. 2nd ed. New York: Mc Craw-Hill, 1988:175-83.
31. Shapiro CL, Henderson IC. Adjuvant therapy of breast cancer. Hematol Oncol Clin North Am 1994;8:213-31.
32. Andersen RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Qual Life Res 1993;2:369-95.
33. Larson PJ, Viele CS, Coleman S, Dibble SL, Cebuski C. Comparison of perceived symptoms of patients undergoing bone marrow transplant and the nurses caring for them. Oncol Nurs Forum 1993;20:81-8.
34. Andrykowski MA, Henslee PJ, Barnett RL. Longitudinal assessment of psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1989;4:505-9.
35. Haberman M. Psychosocial aspects of bone marrow transplantation. Semin Oncol Nurs 1988;4:55-9.
36. Muscari LE. A combined role of clinical nurse specialist and coordinator: optimising continuity of care in an autologous bone marrow transplant program. Clin Nurse Spec 1994;8:48- 55.
37. Buchsel PC. Ambulatory care: before and after BMT. In: Whedon MB, ed. Bone marrow transplantation. Principles, practice and nursing insights. Boston: Jones and Bartlett, 1991: 295-311.
38. Peters WP, Ross M, Vredenburgh JJ, et al. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Semin Oncol 1994;21:25-31.
39. Mundinger MO. Advanced-practice nursing - good medicine for physicians? N Engl J Med 1994;330:211-4.